Search
for
Sort by
Research 541–570 of 1000+
- 밀싹 에탄올 추출물의 C57BL/6 mouse에 대한 발모 효과
- Viviscal: An answer for hair loss in women?
- Crash Dieter's Hair Loss
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Androgen treatment of postmenopausal women
- The rationale for physiological testosterone replacement in women
- The role of R-spondins and their receptors in bone metabolism
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- HEALTH SURVEY OF BOREAL CARIBOU (RANGIFER TARANDUS CARIBOU) IN NORTHEASTERN BRITISH COLUMBIA, CANADA
- Male hormonal contraception: looking back and moving forward
- Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- The Safety of Testosterone Therapy in Women
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner
- Transmasculine Hormone Therapy
- Hereditary Vitamin D Resistant Rickets: Clinical, Laboratory, and Genetic Characteristics of 2 Iranian Siblings
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis
- Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- Isotretinoin
- EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Dienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysis
- Is Frontal Fibrosing Alopecia Connected to Sunscreen Usage?
- A CASE STUDY- AN AYURVEDA APPROACH ON POLYCYSTIC OVARIAN SYNDROME
- <i>JAMA Dermatology—</i>The Year in Review, 2021